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ABSTRACT
Positive supercoils are introduced in cellular DNA in
front of and negative supercoils behind tracking
polymerases. Since DNA purified from cells is
normally under-wound, most studies addressing
the relaxation activity of topoisomerase I have
utilized negatively supercoiled plasmids. The pre-
sent report compares the relaxation activity of
human topoisomerase I variants on plasmids
containing equal numbers of superhelical twists
with opposite handedness. We demonstrate that the
wild-type enzyme and mutants lacking amino acids
1–206 or 191–206, or having tryptophane-205
replaced with a glycine relax positive supercoils
faster than negative supercoils under both proces-
sive and distributive conditions. In contrast to wild-
type topoisomerase I, which exhibited camptothecin
sensitivity during relaxation of both negative and
positive supercoils, the investigated N-terminally
mutated variants were sensitive to camptothecin
only during removal of positive supercoils. These
data suggest different mechanisms of action during
removal of supercoils of opposite handedness and
are consistent with a recently published simulation
study [Sari and Andricioaei (2005) Nucleic Acids
Res., 33, 6621–6634] suggesting flexibility in distinct
parts of the enzyme during clockwise or counter-
clockwise strand rotation.
INTRODUCTION
DNA topoisomerases are essential enzymes that exert
their important cellular roles by relaxing the superhelical
tension that inevitably arises during important DNA
metabolic processes (1,2). Due to the double-helical nature
of DNA, topological challenges are manifested whenever
the two strands are separated to expose the genetic
material. During transcription and replication, positive
supercoils (over-winding of DNA) are generated in front
of and negative supercoils (under-winding) behind the
tracking polymerases (3,4). Topoisomerases of the type IB
family, including eukaryotic and poxviral topoisomerase I
(topo I), relax both positive and negative supercoils by
introducing transient single-strand breaks in the DNA
duplex (5–8). Using an active site tyrosine as a nucleo-
phile, topo I cleaves the DNA backbone and generates a
covalent 3’-phosphotyrosyl linkage and a free 5’-hydroxyl
DNA end. This hydroxyl group acts as a nucleophile in
the ensuing religation reaction, which releases the
covalently bound enzyme and restores the continuity of
the DNA strand. Relaxation occurs in the duration of the
single-stranded DNA break (9,10).
Human topo I is the cellular target for anti-cancer
therapeutics of the camptothecin (CPT) class. These
compounds exert their cytotoxic function by inhibiting
the ligation step of topo I catalysis, thereby trapping
covalent protein–DNA complexes that are converted
into permanent DNA damage upon collision with the
replication and transcription machineries. In addition to
aﬀecting the ligation activity, CPT is known to inhibit the
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single molecule nanomanipulation studies in combination
with in vivo investigations using yeast as a model suggest
that CPT at least in part exerts the cytotoxic eﬀects by
blocking relaxation of positive supercoils (11).
The DNA relaxation event is diﬃcult to address
experimentally. Dynamic details concerning this step
of topo I catalysis is available only in two recent
single-molecule studies, which demonstrate that type IB
topoisomerase-catalyzed DNA relaxation proceeds in a
stepwise torque-dependent manner (12) and that CPTs
slow down the strand rotation step of human topo I
catalysis (11). These results are consistent with the
‘controlled rotation’ mechanism for human topo I as
suggested by Champoux and coworkers (13). According
to this model, DNA relaxation proceeds by rotation of the
free 50-hydroxyl DNA end around the intact strand in
a manner that is restricted by the surrounding protein
(13–15). Considering this model the observed CPT
inhibition of relaxation can be explained by a drug-
induced stalling of the enzyme in a conformation that
prevents strand rotation by spatial blockage of the cleaved
strand imposed by inﬂexible enzyme parts (16,17).
The controlled rotation model is in accordance with the
ability of human topo I to relax supercoils of both signs
(6–8). However, since the direction of rotation will depend
on the sign of the supercoils to be removed, the model also
implies that diﬀerent parts of the enzyme may be involved
in the control of strand rotation during relaxation
of negative versus positive supercoils. At present,
experimental data that discriminate between relaxation
of supercoils with opposite handedness is available for
type II topoisomerases (topo II) (18,19) and at the single
molecule level for wild-type topo I (11). A recent computer
simulation study by Sari and Andricioaei (20) suggested
that relaxation of supercoils of opposite sign by human
topo I involves diﬀerent parts of the enzyme. This issue
was not addressed in the published work (11).
To fully appreciate the ‘Sari and Andricioaei model’
(20), it is necessary to understand the 3D buildup of
human topo I. The enzyme is composed of four domains
deﬁned as the N-terminal (aa 1–206), core (aa 207–635),
linker (aa 636–712) and C-terminal domains (aa 713–765)
(13–15,21–24) of which the latter contains the active site
tyrosine (Tyr-723). Structural data have been obtained
only for residues 201–765 and reveals a clamp-like enzyme
structure embedding the DNA helix in a central protein
pore, with two lobes of the protein each binding their side
of the helix. One lobe is formed by aa 215–433 of the core
domain (the upper cap), which is connected by a ﬂexible
hinge to the ‘lower cap’ composed of aa 434–635, the
C-terminal domain and the anti-parallel coiled-coil linker
domain (13–15,25).
When bound to DNA, human topo I exhibits a closed
conformation in which the two caps bring together two
opposable loop regions (‘the lips’) located diametrically
opposite to the hinge region. It is evident that this
architecture necessitates opening/closing of the protein
clamp during binding and release of DNA, which most
probably is facilitated by motions within the ﬂexible hinge
region (13). As mentioned, the ‘controlled rotation
model’, implies that the clamp structure of human topo
I presents spatial restrictions to the rotation of the free end
of the cleaved DNA strand during the topoisomerization
step of catalysis (13,14,24). An important role in this
process is thought to be played by charged residues in
the linker domain and in the so-called nose cone region of
the upper cap, but other regions may be involved as well
(13,16,23,24). For instance, the N-terminal domain
seems to play a role in the control of strand rotation,
although the function of this region is less clear due to
the lack of extensive structural data (17,26). However,
close interactions of Trp-205 to residues in the ﬂexible
hinge have been reported (23) suggesting that Trp-205
may be important for motions within the hinge region,
which in turn may be involved in the control of strand
rotation. In support of such a mechanism, we previously
demonstrated a role of Trp-205 during DNA topoisome-
rization (17,26). This was manifested by altered relaxation
kinetics of N-terminally mutated or deleted enzymes
and by the DNA relaxation activity of these mutants
being unaﬀected by CPT.
The importance of ﬂexibility within the human topo I
clamp structure during topoisomerization is still a matter
of debate. Two individual investigations have addressed
the eﬀect of covalently closing the protein clamp by
sealing the two opposable lips using disulﬁde bridging.
However, they had contradictory results. One study,
published by Carey and coworkers (27), showed an
unaltered DNA relaxation rate upon closing the protein
clamp. In contrast, Woo et al. (28) found that DNA
relaxation activity was inhibited within the locked protein
clamp structure. It is still uncertain how these conﬂicting
results should be interpreted. The simplest explanation
relies on the diﬀerent positions of the disulﬁde bridges
used to lock the two protein clamps. Woo et al. (28) used a
bridge positioned closer to the catalytic active site than did
Carey and coworkers (27). Hence, the space left for strand
rotation may have been too narrow in the Woo clamp but
suﬃcient to allow relaxation in the Carey clamp.
The molecular dynamics simulation study by Sari and
Andricioaei (20) contributed signiﬁcantly to the discussion
concerning the mechanism of human topo I-mediated
topoisomerization by proposing that two diﬀerent
mechanisms account for the relaxation activity of the
enzyme depending on the handedness of supercoils in
the DNA substrate. Their results, which presuppose the
validity of the ‘controlled rotation model’ (13), predict
that relaxation of positive supercoils requires the loops of
the lips to separate by  10–14A ˚ . Relaxation of negative
supercoils, on the other hand, is expected to involve an
 12A ˚ stretching of the hinge, likely assisted by residues in
the N-terminal domain such as Trp-205 (20). The existing
experimental data to some extent support the predictions.
The two studies that addressed the eﬀect of locking the
topo I clamp by sealing the lips were performed on
positively supercoiled DNA (27,28). One of these studies
demonstrated inhibition of relaxation upon clamp
closure as predicted by the computer simulation (28).
Our previous investigations suggesting the involvement of
N-terminal regions of the enzyme in the control of DNA
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were performed on negatively supercoiled DNA (17,26).
In this study, we addressed the validity of the ‘Sari and
Andricioaei model’ with respect to the putative functions
of N-terminal regions in human topo I during topoisom-
erization. This is accomplished by comparing the activity
of three N-terminally mutated human topo I variants,
HT(207–765) (lacking residues 1–206), HT(191–206)
(lacking residues 191–206) and HT(Trp205Gly) (having
Trp-205 replaced with Gly), with that of the wild-type
enzyme (HT) on positively and negatively supercoiled
DNA substrates. We demonstrate that all four topo I
variants remove positive supercoils faster than negative
supercoils. Moreover, the introduced mutations render the
enzymes insensitive towards CPT in relaxation of negative
but not positive supercoils. These results support the
proposed model and suggest that residues within the
N-terminal region are involved in controlling relaxation of
negative but not positive supercoils.
MATERIALS AND METHODS
Enzymes andmaterials
[g-
32P]ATP (7000Ci/mmol) was from ICN,
oligonucleotides were purchased from DNA technology,
and Me2SO and CPT were from Sigma-Aldrich. CPT was
dissolved in 99.9% Me2SO at 20mM and stored at –208C.
All other chemicals used were analytical reagent grade.
Wild-type human topo I (HT) as well as the four mutant
human topo I enzymes, HT(Trp205Gly), HT(191–206),
HT(207–765) and HT(Tyr723Phe) were expressed in the
Saccharaomyces cerevisiae top1 null strain RS190 (a kind
gift from R. Sternglanz, State University of New York,
Stony Brook, NY, USA) and puriﬁed as described
previously (17). Positively supercoiled pBR322 was
prepared by incubating negatively supercoiled plasmid
with Archaeoglobus fulgidus reverse gyrase as described
(18,19). The average number of superhelical twists present
in the DNA plasmids was determined by electrophoretic
band counting relative to fully relaxed molecules.
Positively supercoiled plasmids contained  15–17 positive
superhelical twists per molecule (  +0.035 to +0.039)
and negatively supercoiled plasmid molecules
each contained  15–17 negative superhelical twists
(s    0.035 to –0.039) (18,19).
AssayforhumantopoI-mediatedrelaxationofplasmidDNA
DNA relaxation reactions at processive conditions were
carried out in 20ml reaction volumes in the presence of
10mM Tris–HCl (pH 7.5), 1mM EDTA, 5mM MgCl2
and 5mM CaCl2. The enzyme storage buﬀer additionally
provided 15mM NaCl, 2.5% glycerol, 0.25mM Tris–HCl
(pH 7.5) and 0.025mM EDTA to the reaction. DNA
relaxation activity at distributive conditions was assayed
as described for processive conditions, except that
additional NaCl was supplied to the reaction buﬀer,
providing a NaCl concentration corresponding to the salt
optima of the individual enzymes as reported previously
[150mM for HT, 100mM for HT(Trp205Gly) and
HT(191–206),and 75mM for HT(207–765) (17,26)].
When indicated, a ﬁnal concentration of 60mM CPT
dissolved in Me2SO [10% (v/v) ﬁnal concentration]
was added to DNA relaxation reactions at processive
conditions. Control reactions with no addition of CPT
were supplied with Me2SO [10% (v/v) ﬁnal concentration].
A total of 100fmol of pBR322 were incubated with
puriﬁed recombinant enzyme at 378C for the indicated
time intervals. Reactions were terminated by the addition
of SDS to a ﬁnal concentration of 0.2% (w/v). Samples
were subjected to proteolytic digestion by 0.5mg/ml
of proteinase K at 378C for 30min prior to separation
of reaction products in a 1% agarose gel. DNA was
visualized by staining the gel with 0.5 mg/ml ethidium
bromide and relaxation products were analyzed using the
Bio-Rad Gel Doc-2000 system.
Since positively supercoiled plasmids bind ethidium
bromide less eﬃcient than negatively supercoiled
plasmids, DNA concentrations were determined by
spectrophotometric analysis and conﬁrmed by ethidium
bromide staining of plasmids linearized with HindIII.
Assay forhuman topo I-mediated cleavage ofplasmid DNA
DNA cleavage reactions were conducted by incubating
100fmol of positively or negatively supercoiled pBR322
with each of the four enzymes in a reaction buﬀer
containing 10mM Tris–HCl (pH 7.5), 1mM EDTA,
5mM MgCl2 and 5mM CaCl2. Additionally, 15mM
NaCl, 2.5% glycerol, 0.25mM Tris–HCl (pH 7.5) and
0.025mM EDTA was supplied by the enzyme storage
buﬀer. Twenty microliter reactions were incubated at 378C
for 2min and quenched by the addition of 0.2% (w/v)
SDS. Samples were treated with proteinase K as described
above and analyzed by separation in a 1% agarose gel
containing 0.35 mg/ml ethidium bromide.
Assay forhuman topo I-mediated DNA binding
Non-covalent DNA binding by HT(Tyr723Phe) to posi-
tively and negatively supercoiled plasmid DNA was
assessed using a competitive nitrocellulose ﬁlter-binding
assay. The enzyme was incubated with 2.5nM of a
50-radiolabeled 100-mer synthetic DNA duplex substrate
in a 20ml reaction volume containing 10mM Tris–HCl
(pH 7.5), 1mM EDTA, 5mM MgCl2 and 5mM CaCl2
and [15mM NaCl, 2.5% glycerol, 0.25mM Tris–HCl
(pH 7.5) and 0.025mM EDTA] supplied by the enzyme
storage buﬀer. Binding reactions were carried out at 378C
for 15min in the absence or presence of indicated amounts
of negatively or positively supercoiled competitor pBR322
plasmid ranging from 0 to 20nM. A nitrocellulose
membrane (Protran, Scleicher & Schuell Bioscience) was
prepared by treatment with 0.1 mg/ml salmon testis DNA
for 1h at room temperature. Samples were applied to
the membrane and ﬁltered in vacuo. Subsequently the
membrane was washed four times with a buﬀer containing
50mM NaCl, 10mM Tris–HCl (pH 7.5), 1mM EDTA
5mM MgCl2 and 5mM CaCl2.
The sequence of the synthetic 100-mer DNA substrate
is: Top strand: 50CGA ATT CGC TAT AAT GCC TGC
AGG TCG ACT CTA GAG GAT CTA AAA GAC TTA
GAA AAA TTT TTG GCT TAA GCA ACA TAT GGT
6172 Nucleic Acids Research, 2007, Vol. 35, No. 18ATC GTC GGA ATT CAA TGA G-30 and bottom
strand: 50-CTC ATT GAA TTC CGA CGA TAC CAT
ATG TTG CTT AAG CCA AAA ATT TTT CTA AGT
CTT TTA GAT CCT CTA GAG TCG ACC TGC AGG
CAT TAT AGC GAA TTC G-30. The top strand of the
substrate was 50-radiolabeled prior to hybridization to the
bottom strand by applying the T4 polynucleotide kinase
reaction using [g-
32P]ATP as the phosphoryl donor.
Unreacted ATP was removed by dialysis on a G-50
column. For hybridization 10 pmol of the top strand and
15pmol of the bottom strand were mixed, heated to 858C
and slowly cooled to room temperature.
The relative amount of radioactive DNA substrate
bound by the enzyme was determined as the amount of
radioactivity retained on the membrane using a model SF
Molecular Dynamics Phosphorimager and quantiﬁed
using the QuantityOne software (BioRad).
RESULTS
Kinetics ofDNA relaxation mediated by HT,HT(207–765),
HT"(191–206), and HT(Trp205Gly) on positively and nega-
tively supercoiled plasmids
At present, only a few studies have addressed the
relaxation of positively supercoiled DNA by HT and
most of them have been restricted due to limitations posed
by the available substrates (6–8). Positively supercoiled
plasmids have been generated mainly by the use of
intercalating agents or by subjecting a relaxed plasmid
to signiﬁcantly increased temperature. At these conditions,
positive supercoils arise as a compensation of local
unwinding of the double helix. However, these methods
are not readily controlled to produce under- or over-
wound DNA with equal numbers of supercoils of opposite
sign allowing factors other than topoisomerase action on
DNA topology to be ruled out. Due to these limitations,
only one recently published report based on single-
molecule nanomanipulation (using magnetic tweezers to
introduce supercoils of either sign in single DNA
fragments) has directly compared the relaxation kinetics
of topo I on positively and negatively supercoiled
substrates (11).
In the present study, we use enzymatically generated
substrates containing equal amounts of positive or
negative supercoils to address the inﬂuence of supercoil
handedness on topo I activity. These substrates are
comparable in all parameters other than the sign of the
supercoils. Positively supercoiled substrate was prepared
by incubating pBR322 with A. fulgidus reverse gyrase.
Negatively supercoiled substrate was obtained by purify-
ing pBR322 from Escherichia coli, which naturally
maintains all DNA in an under-wound state. The
preparation and characterization of both substrates were
performed as previously reported by McClendon et al.
(19) and will not be described further here. It should be
noted, however, that the two substrates each contained
15–17 supercoils of opposite sign.
To compare the relaxation of the positively and
negatively supercoiled plasmids by HT, HT(207–765),
HT(191–206), HT(Trp205Gly) each of the enzymes was
puriﬁed to homogeneity as described previously (17,26).
The puriﬁed fractions were analyzed in a 10% SDS–
polyacrylamide gel and the proteins visualized by
Coomassie staining. As evident from Figure 1, only a
single band with a mobility corresponding to the expected
size of the respective topo I variants could be observed in
each of the four enzyme preparations. The identity of the
puriﬁed proteins as topo I variants were further conﬁrmed
by western blot analysis using a human topo I-speciﬁc
antibody (data not shown).
The relaxation of positively and negatively supercoiled
pBR322 by the four topo I variants was assayed under
processive and distributive conditions. Processive condi-
tions were facilitated by a low salt buﬀer (15mM NaCl,
coming from the enzyme preparations and 5mM MgCl2)
using an enzyme:plasmid ratio of  1:1. Under these
conditions, each of the four topo I variants have
previously been shown to relax negatively supercoiled
DNA by completing relaxation of the bound DNA
substrate before attacking another substrate (29). Hence,
the rate-limiting step of catalysis under these conditions is
expected to be mainly the strand rotation while the
association/dissociation and cleavage/ligation rates are
expected to have less eﬀect on the overall reaction rate.
Ideally a molar excess of enzyme compared to plasmid
should have been used to limit the eﬀect of association/
dissociation on the relaxation rate as much as possible.
However, within the technical limitation of this assay, it
was impossible to obtain quantitative data on relaxation
of positive supercoils using a higher enzyme concentration
since under these conditions relaxation of positively
supercoiled substrates was completed within <5s (data
not shown).
The relative activities of the four topo I variants on
negatively supercoiled substrates have been addressed in
previously published comparative investigations (17,26).
In this study, to ease the comparison of their activities
on plasmids with positive relative to negative supercoils,
the concentration of each enzyme was adjusted to give
similar activity on negatively supercoiled substrates
(Figure 2A–D, lanes 1–7). In the experimental setup,
HT
HT(207–765)
HT(Trp205Gly)
HT∆(191–206)
M
12345
kDa
- 60
- 70
- 85
-100
-120
-150
Figure 1. Puriﬁcation of HT, HT(191–206), HT(Trp205Gly) and
HT(207–765). Puriﬁed, recombinant enzymes HT (lane 1), HT(207–765)
(lane2), HT(191–206) (lane 3) and HT(Trp205Gly) (lane 4) were
analyzed by SDS–PAGE and visualized by Coomassie staining.
M, protein marker.
Nucleic Acids Research, 2007, Vol. 35, No. 18 6173300ng of either positively or negatively supercoiled
pBR322 were incubated with each of the enzymes HT,
HT(Trp205Gly), HT(191–206) or HT(207–765) for
increasing time periods as shown in Figure 2. Reaction
products were analyzed in a 1% agarose gel without
ethidium bromide. Following electrophoresis, the DNA
was visualized by ethidium bromide staining. Note that
positively supercoiled plasmids bind ethidium bromide
less eﬃciently than negatively supercoiled plasmids and
are, hence, stained less intensively than the corresponding
amount of negative supercoiled plasmids. Therefore, to
make sure that equal amounts of substrates were used in
all experiments, the DNA concentration was measured by
spectrophotometric analysis and by ethidium bromide
staining of plasmids in the master reaction mixture after
linearization by digestion with HindIII (Figure 2E).
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Figure 2. Relaxation activity of HT, HT(191–206), HT(Trp205Gly) and HT(207–765) on positively or negatively supercoiled plasmid at processive
conditions. Relaxation activities of HT (A), HT(Trp205Gly) (B), HT(191–206) (C) or HT(207–765) (D) were assayed at processive conditions by
incubating 300ng negatively (left panels) or positively (right panels) supercoiled pBR322 plasmid with each of the four enzymes at 378C in an molar
enzyme:plasmid ratio of 1:1. Reactions were stopped by addition of 2% (w/v) SDS after indicated periods of time. Following proteinase K digestion,
samples were analyzed in a 1% agarose gel stained with ethidium bromide subsequent to electrophoresis. The presented gel picture is a representative
of three independent experiments. (E) 300ng of negatively (lane 1) and positively (lane 2) supercoiled pBR322 plasmid was linearized by HindIII
digestion. Graphic depiction of the results are shown in the right panel. Relaxation activity is calculated as the relative loss of supercoiled substrate
left after incubation and plotted as a function of incubation time. Filled squares: represent the relaxation of positive supercoils, open triangles:
represent relaxation of negative supercoils. SC, supercoiled pBR322. R, relaxed pBR322. L, linearized pBR322.
6174 Nucleic Acids Research, 2007, Vol. 35, No. 18By comparing lanes 1–7 with lanes 8–14 of Figure 2A–D,
it is evident that each of the four topo I variants relaxed
the positively supercoiled substrate faster than the negativ-
ely supercoiled substrate. Relaxation by all four enzymes
proceeded in a processive manner at the investigated assay
conditions and no obvious diﬀerence in the relaxation
mode of the positively and negatively supercoiled sub-
strates was observed for any of the enzymes. Therefore,
the relative activities of the enzymes on the two substrates
could be estimated rather simply by measuring the amount
of fully supercoiled substrate left after the diﬀerent
incubation time periods. Graphical depictions of these
measurements are shown in the right panel of Figure 2,
where the relaxation activity in each lane is calculated as
the loss of fully supercoiled substrate relative to the
total amount of plasmids. As evident from the graphs the
four human topo I variants HT, HT(Trp205Gly),
HT(191–206) and HT(207–765) relaxed positively super-
coiled plasmids 20–50 times faster than the negatively
supercoiled substrates.
A similar experiment was carried out under distributive
conditions which is facilitated by a high salt buﬀer
(corresponding to the optimal salt concentration
for each enzyme, see Materials and Methods section)
and molar excess of plasmid compared to enzyme.
At these conditions the association/dissociation and the
cleavage/ligation rates are expected to be rate limiting for
DNA relaxation. The results of incubating negatively or
positively supercoiled plasmids with each of four topo
I variants in a molar ratio of 10:1 under high-salt
buﬀer conditions for increasing time periods are shown
in Figure 3. As evident from the graphical depictions
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Figure 3. Relaxation activity of HT, HT(191–206), HT(Trp205Gly) and HT(207–765) on positively or negatively supercoiled plasmid at distributive
conditions. Relaxation activities of HT (A), HT(Trp205Gly) (B), HT(191–206) (C) or HT(207–765) (D) were assayed at distributive conditions by
incubating 300ng negatively (left panels) or positively (right panels) supercoiled pBR322 plasmid with each of the four enzymes at 378C in an molar
enzyme:plasmid ratio of 1:10. Except for these alterations, the experiment was carried out as relaxation under processive conditions shown in
Figure 2. Right panel is a graphical depiction of the results, where relaxation activity is calculated as the relative loss of supercoiled substrate left
after incubation and plotted as a function of incubation time. Filled squares: represent the relaxation of positive supercoils, open triangles: represent
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Nucleic Acids Research, 2007, Vol. 35, No. 18 6175of the relaxation activities of HT, HT(Trp205Gly),
HT(191–206) and HT(207–765) (calculated as described
for processive relaxation) all four topo I variants were
stimulated 3- to 10-fold by positive supercoils.
Effects of DNA supercoil geometry on DNA cleavage and
non-covalentbinding
To address whether the increased relaxation rate on
positively supercoiled substrates observed in this study
could simply be ascribed to enhanced cleavage eﬃciencies
of the four human topo I variants on positively relative
to negatively supercoiled substrates, a cleavage assay was
performed. For this purpose the amount of cleavage
complexes trapped by the addition of 0.2% SDS (w/v)
after 2min of incubation of positive or negative super-
coiled plasmids with a surplus of HT, HT(Trp205Gly),
HT(191–206) or HT(207–765) was compared. This type
of experiment is hampered by the fact that cleavage by
topo I is rapidly followed by relaxation, which converts
the supercoiled plasmids to the relaxed form. In an
attempt to circumvent this problem, the experiment was
carried out for a short time period under processive
conditions in which the enzyme tends to remain bound to
the original DNA for an extended period of time. We
therefore believe that the detergent-trapped cleavage
pattern reﬂects the initial cleavage of supercoiled plasmids
as much as possible.
As evident from Figure 4, the four topo I variants
maintain a slightly (<2-fold) higher level of cleavage with
positively relative to negatively supercoiled substrates
(Figure 4A top panel, compare lanes 3 with 4, 5 with 6, 7
with 8 and 9 with 10, for quantiﬁcations see lower panel of
Figure 4A). This result is consistent (within the scope of
expected deviations) with a previous report demonstrating
 2- to 3-fold stimulation of wild-type topo I cleavage on
positively supercoiled substrates (18).
Due to the mentioned limitations of the cleavage assay
we also tested the eﬀect of supercoil handedness on non-
covalent DNA binding. This was done using a competitive
DNA-binding assay (Figure 4B). In this assay, the ability
of negatively or positively supercoiled plasmids to
compete with a 100-mer radiolabeled synthetic DNA
substrate for binding to a human topo I variant lacking
the active site tyrosine HT(Tyr723Phe) was monitored on
nitrocellulose membranes. HT(Tyr723Phe) was used to
avoid cleavage, which is rapidly followed by relaxation
and, hence, alteration of the plasmid topology. The
enzyme was incubated with radiolabeled substrate and
positively or negatively supercoiled plasmid simulta-
neously for 15min before the samples were transferred
to the membrane that retains protein bound DNA. As
evident from Figure 4B, no signiﬁcant diﬀerence in the
aﬃnity of HT(Tyr723Phe) for positively or negatively
supercoiled substrate was observed.
Effects of CPTon the relaxation ofpositively or negatively
supercoiled substratesby HT, HT(207–765),HT"(191–206)
andHT(Trp205Gly)
We have previously shown that although the DNA
religation activities of HT(Trp205Gly), HT(191–206)
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Figure 4. Cleavage activity of HT, HT(191–206), HT(Trp205Gly)
and HT(207–765) on positively or negatively supercoiled plasmid.
(A) Cleavage activity of the four human topo I variants was assessed by
incubating the individual enzyme with negatively (lanes 1,3,5,7 and 9) or
positively (lane 2, 4, 6, 8 and 10) supercoiled plasmid at 378C. After 2min,
reactions were quenched by the addition of 2% (w/v) SDS followed by
treatment with proteinase K. Samples were analyzed in a 1% agarose gel
containing ethidium bromide. The presented gel picture is chosen as a
representative of three independent experiments. Lanes 1 and 2, substrate
controls. No enzyme added. Lanes 3 and 4, HT. Lanes 5 and 6,
HT(Trp205Gly). Lanes 7 and 8, HT(191–206) and lanes 9 and 10,
HT(207–765). The lowerpanelisagraphicdepiction showingthe cleavage
activitycalculatedasthepercentageofthesupercoiledsubstrateconverted
to the nicked form. (B) Binding of HT(Tyr723Phe) to negatively and
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positively supercoiled pBR322 to compete with binding of 2.5nM
radiolabeled 100-mer linear substrate DNA by the HT(Tyr723Phe). The
amount of bound linear DNA was determined by measuring the
radioactivity retained on a nitrocellulose ﬁlter. Binding to the radioactive
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plasmid was normalized relative to binding in the absence of competitor.
(–)SC, negatively supercoiled pBR322. (+)SC positively supercoiled
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6176 Nucleic Acids Research, 2007, Vol. 35, No. 18and HT(207–765) display wild-type sensitivity to CPT,
their ability to relax negative supercoils is unaﬀected by
the drug. In contrast, DNA relaxation activity of wild-
type human topo I on negatively supercoiled DNA is
severely inhibited by CPT (26). To address how CPT
inﬂuences the relaxation of supercoils with diﬀerent
handedness by the four enzyme variants, we compared
the eﬀects of CPT on the relaxation of positively and
negatively supercoiled substrates mediated by HT,
HT(Trp205Gly), HT(191–206) or HT(207–765). First,
it was conﬁrmed that DNA ligation by all four enzyme
preparations was inhibited by CPT to a comparable level
(data not shown). Next, 300ng of either negatively or
positively supercoiled pBR322 were incubated with each
of the human topo I variants in the absence or presence of
60 mM CPT for increasing time periods as stated in
Figure 5. For comparison, 10% Me2SO was added to
reactions performed without CPT to match the conditions
in samples containing the drug that was dissolved in
Me2SO. Note that in this experiment, enzyme concentra-
tions were adjusted to allow the relaxation rates of either
positive or negative supercoils with or without added CPT
to be compared. Due to the very diﬀerent relaxation rates
on positively versus negatively supercoiled substrates and
the limitations of incubation times posed by drug and
enzyme stability, the eﬀects of CPT on the relaxation of
either substrate could be allowed only by using  10-fold
more enzyme for relaxation of negative (enzyme:plasmid
ratio 1:1) than positive supercoils (enzyme:plasmid ratio
1:10). Hence, the experiments are not designed to allow
relaxation of the two substrates to be compared directly,
but only to address the relative eﬀects of CPT.
Relaxation of negatively supercoiled plasmid DNA by
HT was inhibited  150 times by the presence of CPT
when estimated from the amount of fully supercoiled
substrate remaining after incubation for 0.25 or 40min in
the absence or presence of drug, respectively (Figure 5A,
compare lane 2 with lane 12, see also right panel for
quantiﬁcations). HT(Trp205Gly), HT(191–206) and
HT(207–765) were largely unaﬀected by CPT when
relaxing negative supercoils (Figure 5B–D, lanes 1–12).
These results are consistent with our previously published
observations (26).
When positively supercoiled plasmid was used as the
substrate for relaxation activity the situation changed
dramatically. On this substrate all four topo I variants
were inhibited  40- to 60-fold upon addition of CPT to
the reaction mixtures (Figure 5A, compare lanes 16 and
24, and Figure 5B–D, compare lanes 16 and 25). As will be
discussed, these results support a model where the regions
of the enzyme engaged in control of strand rotation
depend on the sign of the supercoils to be relaxed.
DISCUSSION
The present study was prompted by the ‘Sari and
Andricioaei model’ for HT, which implies diﬀerent
mechanisms of relaxation depending on the handedness
of the supercoils to be removed (20). To address this
possibility experimentally, we have compared the abilities
of human topo I and variants mutated or deleted in the
N-terminal domain to relax plasmid substrates with an
equal number of either positive or negative supercoils. As
a result of these studies, we ﬁnd that HT, HT(Trp205Gly),
HT(191–206) and HT(207–765) all relax positively
supercoiled plasmids  20–50 times faster than negatively
supercoiled plasmid DNA under processive conditions
(molar enzyme:plasmid ratio of  1:1, low salt buﬀer) and
3–10 times faster under distributive conditions (molar
enzyme:plasmid ratio of  1:10, high salt buﬀer). Cleavage
activity was slightly (<2-fold) higher on positively super-
coiled compared to negatively supercoiled substrates
whereas no diﬀerence in binding aﬃnity between the two
substrates was observed. The relatively modest stimula-
tion of relaxation by positive supercoils under distributive
conditions may be explained by the modest stimulation of
cleavage. The more drastic stimulation of relaxation under
processive conditions by positive supercoils is unlikely to
be accounted for solely by an increased cleavage rate.
In surplus of enzyme, the relaxation rate under processive
conditions is generally accepted to depend mainly on the
speed of strand rotation. Due to technical limitations of
our assay, we were not able to perform quantitative
analyses using surplus of enzyme for the relaxation of
both positive and negative supercoils. However, although
not being able to determine the fold stimulation (relaxa-
tion of positive supercoils was completed too fast) we did
observe signiﬁcantly faster relaxation of positive versus
negative supercoils also when using a molar enzyme:plas-
mid ratio of 5:1 (data not shown). This argues in favor of
strand rotation being faster during relaxation of positively
supercoiled DNA. In indirect support of this model is the
observation that positive supercoils were relaxed relatively
faster than negative supercoils under processive compared
to distributive conditions. If increased binding/cleavage
rates were the main determinant of the stimulated
relaxation by positive supercoils, one would expect a
more pronounced stimulation of the reaction under
distributive rather than under processive conditions,
which contradicts our observations. Based on these
arguments we believe that strand rotation is faster
during uncoiling of positive relative to negative supercoils.
A recently published single-molecule nanomanipulation
study where relaxation was monitored on a single DNA
fragment in which supercoils were introduced by magnetic
tweezers did not reveal a signiﬁcant diﬀerence in the rate
of positive or negative supercoil removal by human topo I
(11). However, a bias towards a higher velocity in the
uncoiling of positive compared to negative supercoils was
observed even at the single DNA molecule level and
within the second scale time frame of the experiment (11).
Since diminutive eﬀects at the single molecule level will be
accumulative in our experimental setup performed on a
population of substrate and enzyme molecules in a minute
scale time frame, we believe that the results obtained by
the single molecule technology do not contradict the
observations reported here.
Positive supercoils are primarily generated in cellular
DNA ahead of DNA tracking processes such as replica-
tion and transcription (3,30). During recent years it
has been a matter of debate which of the eukaryotic
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6178 Nucleic Acids Research, 2007, Vol. 35, No. 18topoisomerases topo I, topo IIa or IIb are mainly
responsible of removing such supercoils (19,31,32).
Although necessary for ongoing replication and transcrip-
tion, topoisomerase action in front of DNA tracking
processes also poses a cellular risk, since collision with
polymerases convert accidentally trapped cleavage com-
plexes to permanent DNA damage (33–35). Hence, a
potent relaxation activity associated with the lowest
possible occurrence of cleavage complexes at any given
time may be favorable to cells. This consideration leads to
the recent suggestion of topo IIa being a safe key player in
the removal of topological stress ahead of DNA tracking
polymerases since this enzyme shows a >10–fold stimu-
lated relaxation activity and a decreased cleavage activity
on positively compared to negatively supercoiled plasmids
(18,19). The stimulation of human topo I relaxation by
positive supercoils associated with only a slightly
enhanced cleavage activity reported here also argues in
favor of human topo I being an important cellular factor
in the relaxation of positive supercoils. This notion is
supported by the recent ﬁnding that positive supercoils
accumulate in yeast cells upon CPT-induced inhibition of
topo I relaxation activity (11).
We have shown previously that the relaxation activities
of HT(207–765), HT(191–206) and HT(Trp205Gly) on
negatively supercoiled plasmid DNA are unaﬀected by
CPT (26). This result was conﬁrmed in the present study.
More interestingly, we found that relaxation of positive
supercoils by all four enzymes [(HT, HT(Trp205Gly),
HT(191–206) and HT(207–765)) were inhibited 40- to
60-fold by CPT. In our hands the inhibition of positive
supercoil relaxation by HT was less pronounced than was
the inhibition of negative supercoil relaxation (150-fold
inhibition). This result contradicts recently published data
obtained by single DNA molecule and in vivo investiga-
tions suggesting a more pronounced drug inhibition of
positive supercoil than of negative supercoil removal by
human topo I. The reason for this diﬀerence is not clear. It
may in part reﬂect diﬀerent timescales and drug concen-
trations used in the two experimental setups. For the aim
of the present study, however, the important thing to note
is the comparable drug inhibition level of all four human
topo I variants when relaxing positive supercoils as
opposed to the lack of inhibition of HT(Trp205Gly),
HT(191–206) and HT(207–765) during relaxation of
negative supercoils.The inhibitory eﬀect of CPT on DNA
relaxation by human topo I is believed to result from a
drug induced stalling of the enzyme in a rather rigid
conformation that hinders rotation of the cleaved DNA
strand around the intact strand due to collision with the
‘frozen’ enzyme (16,17). In favor of this theory the ﬂexible
linker domain has only been crystallized in protein–DNA
complexes bound by a CPT derivative suggesting that
drug binding renders the linker region inﬂexible
(25,36). In further support of the notion that drug
inhibition of DNA relaxation is mediated by spatial
restrictions posed by the bound enzyme is that various
deletions and/or mutations (including the mutations
described in this study) of human topo I leave the
enzyme insensitive towards CPT in relaxation of negative
supercoils without aﬀecting the drug-induced inhibition
of ligation (16,17,26). Based on this model for CPT
inhibition of relaxation, we believe the diﬀerent responses
of the mutated enzymes towards CPT when relaxing
positive versus negative supercoils reﬂect diﬀerent mechan-
isms of strand rotation being engaged in the removal of
supercoils of opposite sign. More speciﬁcally, the sensitiv-
ity of the N-terminally mutated enzymes HT(Trp205Gly),
HT(191–206) and HT(207–765) towards CPT during
relaxation of positively but not negatively supercoiled
plasmids suggest a role of Trp-205 and possibly surround-
ing residues in the control of strand rotation during the
removal of negative but not positive supercoils.
The recently published computer simulations of con-
trolled strand rotation by human topo I performed by
Sari and Andricioaei suggest stretching of the hinge region
in topo I to be prerequisite during relaxation of negative
supercoils, and separation of the lips to be required when
positive supercoils are removed (20). The experimental
data presented here support the simulation model in terms
of the involvement of the hinge region in the removal of
negative supercoils since both structural and biochemical
evidence suggest that Trp-205 and surrounding residues
controls motions within the hinge. Hence, based on the
available evidence, we suggest that the absence of
important N-terminal residues leads to a constitutively
stretched conformation of the hinge region allowing a
rather uncontrolled clockwise strand rotation during
the removal of negative supercoils as implied by the
‘Sari and Andricioaei model’ (20). As suggested by the
same authors, stretching of the hinge region may have
little or no eﬀect on the conformation of the lips, which
they believe to be involved in the control of counter-
clockwise strand rotation during relaxation of positive
supercoils. This in turn is consistent with the CPT
sensitivity of HT(Trp205Gly), HT(191–206) and
HT(207–765) in the relaxation of positive supercoils
presented here.
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